NCT02265939View on ClinicalTrials.gov

Phase Ⅱ Dose Response Study of NPO-13 in Patients Undergoing Total Colonoscopy

PHASE2CompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Bowel Disease
Interventions
DRUG

NPO-13

Trial Locations (3)

Unknown

Fukuoka

Osaka

Tokyo

Sponsors
All Listed Sponsors
lead

Nihon Pharmaceutical Co., Ltd

INDUSTRY